
GLP-1 boom in China, India, Brazil could create $22bn market by 2035, J.P. Morgan says
The combined China-India-Brazil market for weight-loss drugs could grow to $22 billion by 2035 from $6.6 billion currently, J.P. Morgan estimated, as improving affordability and broader access drive adoption in largely untapped patient populations.



























_20251003092603298_af0c50_20251010094012153_327c07.webp)































_20260101112329999_0153db.webp)


























